Seeing Is Believing

Currently out of the existing stock ratings of James Lee, 382 are a BUY (70.09%), 17 are a SELL (3.12%), 146 are a HOLD (26.79%).
Analyst James Lee, currently employed at MIZUHO, carries an average stock price target met ratio of 59.13% that have a potential upside of 37.61% achieved within 165 days.
James Lee’s has documented 1,211 price targets and ratings displayed on 54 stocks. The coverage is on Communication Services, Consumer Cyclical, Healthcare, Technology, Financial Services sectors.
Most recent stock forecast was given on JD, JD.com Adr at 19-Nov-2025.
Analyst best performing recommendations are on CORT (CORCEPT THERAPEUTICS).
The best stock recommendation documented was for TRIP (TRIPADVISOR) at 5/7/2024. The price target of $20 was fulfilled within 1 day with a profit of $5.48 (21.51%) receiving and performance score of 215.07.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 13-Feb-2026
$125
$-7.85 (-5.91%)
$122
4 months 20 days ago
(11-May-2026)
2/7 (28.57%)
$-12.05 (-8.79%)
19
Buy Since 05-May-2025
$162
$29.15 (21.94%)
$150
4 months 20 days ago
(11-May-2026)
14/24 (58.33%)
$24.95 (18.21%)
89
Buy Since 20-Apr-2022
$175
$42.15 (31.73%)
$158
4 months 23 days ago
(08-May-2026)
14/18 (77.78%)
$33.51 (23.68%)
152
Buy Since 11-Apr-2024
$160
$27.15 (20.44%)
$145
4 months 23 days ago
(08-May-2026)
3/10 (30%)
$18.51 (13.08%)
154
Buy Since 08-May-2026
$173
$40.15 (30.22%)
$170
4 months 23 days ago
(08-May-2026)
13/16 (81.25%)
$31.51 (22.27%)
30
What Year was the first public recommendation made by James Lee?